Chemoimmunotherapy Responses May Allow for Omission of Radiotherapy in Lymphoma

Patients with a subtype of lymphoma may be able to exclude radiotherapy if they respond to chemoimmunotherapy, although more follow-up is needed to assess potential long-term toxicities.

Related Keywords

Rome ,Lazio ,Italy ,Maurizio Martelli ,University Sapienza ,Eha Congress 2023 ,Lymphoma ,